Synta
Navigation Links
Synta in Medical News
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
... Drop Adventrx Pharmaceuticals, Inc. (Amex: ANX ) Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) Add Dyanvax Technologies (Nasdaq: DVAX ) synta Pharmaceuticals Corp. (Nasdaq: SNTA ) Enabling Technologies Index (HHV) Drop Hillenbrand Industries (NYSE: HB ) Add Eurand N.V. (Nasdaq: EU......trading on March 10, 2008, ISIS Pharmaceuticals (Nasdaq: ISIS ) will replace Pharmion Corp. (Nasdaq: PHRM ) in the HealthShares(TM) Composite Index. synta Pharmaceuticals Corp. (Nasdaq: SNTA ) will replace Pharmion Corp. (Nasdaq: PHRM ) in the Cancer Index. Pharmion is being acquired by Celgene Corp. (...
New type of drug shows promise in attacking melanoma in an innovative way
...of time patients survived without progression of their cancer. The study, according to Dr Anthony Williams, vice president of clinical research at synta Pharmaceuticals Corp. in Lexington, Massachusetts, USA, included 81 patients with metastatic melanoma. Of those, 28 received treatment with the chemot...Synta in Medical Technology
...ped under a global collaboration agreement
between synta Pharmaceuticals and GlaxoSmithKline.
Ongoing Clinical Trials
GlaxoSmithKline and synta Pharmaceuticals are currently studying
elesclomol ...t GlaxoSmithKline at http://www.gsk.com .
About synta Pharmaceuticals Corp.
...
GlaxoSmithKline Reports Further Progress of Oncology Portfolio
...demark of the GlaxoSmithKline group of companies in the United States. *Elesclomol is being developed under a global collaboration agreement between synta Pharmaceuticals and GSK. Cautionary statement regarding forward-looking statements Under the safe harbor provisions of the U.S. Private Securiti...Synta Oncology Candidate STA-4783 Clinical Trial Results to Be Presented at the ASCO Annual Meeting
...th stage IV metastatic melanoma. In November 2006, synta received Fast Track designation from the FDA for t...he development of STA-4783 in metastatic melanoma. synta plans to initiate a pivotal Phase 3 clinical trial...t of metastatic melanoma in over 30 years. About synta Pharmaceuticals ...Synta Pharmaceuticals to Host Conference Call Today
...will be archived on the Company's website. About synta Pharmaceuticals synta Pharmaceuticals Corp. is a biopharmaceutical compa...ncluding cancer and chronic inflammatory diseases. synta has a unique chemical compound library, an integra...Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
...STA-4783 Fast Track designation in November, 2006. synta plans to initiate a Phase 3 clinical trial to inve...th stage IV metastatic melanoma. In November 2006, synta received Fast Track designation from the FDA for t...he development of STA-4783 in metastatic melanoma. synta plans to initiate a pivotal Phase 3 clinical trial...Synta in Biological Technology
Microbia Names John McCarthy to Senior Management Team
...or Vice President and Chief Financial Officer for Xanthus Pharmaceuticals, Senior Vice President Corporate Development and Chief Financial Officer for synta Pharmaceuticals, Executive Vice President, Chief Operating Officer and Chief Financial Officer for Exact Sciences, and President of the Managed Care D...Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...KT) EXELIXIS INC. (NASDAQ: EXEL ) HUMAN GENOME SCIENCES INC. (NASDAQ: HGSI ) MEDAREX INC (NASDAQ: MEDX ) SEATTLE GENETICS INC (NASDAQ: SGEN ) synta PHARMACEUTICALS CORP (NASDAQ: SNTA ) ZYMOGENETICS INC (NASDAQ: ZGEN ) Add ABRAXIS BIOSCIENCE INC (NASDAQ: ABII ) CHUGAI PHARM CO (Tokyo SE: 4......HHJ) Drop Adventrx Pharmaceuticals, Inc. (Amex: ANX ) Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) Add Dyanvax Technologies (Nasdaq: DVAX ) synta Pharmaceuticals Corp. (Nasdaq: SNTA ) Enabling Technologies Index (HHV) Drop Hillenbrand Industries (NYSE: HB ) Add Eurand N.V. (Nasdaq: EURX...
Other TagsRageRageRageRageRageRageFellOther Contentspsoriaticpsoriaticpsoriaticpsychosispsychosispsychosisfibrosisfibrosisfibrosisfibrosisfibrosisfibrosisfibrosisfibrosisvenoptosispulsepulsepulsepulsepulsepulsepulsepulsepulsepubertypubertypubertypuberty
DisenchantingschoolboyfretsRageimmediatelyUpfrontAlleviatingMaestroStaleFellCopycatCefotaximeDisplaceCheeks
(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2[0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification[0] Distributor Announces New Applications for Wind Turbines [0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children[0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment[0] BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How to read brain activity? 2New therapy targets for amyloid disease 2Climbing to new heights in the forest canopy 9503 1Climbing to new heights in the forest canopy 9503 2Sperm Cell Insights May Aid Stem Cell Research 53867 1Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 1Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 2Wrongful Death Lawsuit for Tyler R Hill Against Ambassadors Group docleaf et al Officially Settled 53862 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |